Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Alexion's (ALXN) Earnings Streak End?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 11:50am
tags:
Alexion, earnings
GlaxoSmithKline plc And Its Drive For Growth
Motley Fool, UK
Tuesday, January 28, 2014 - 11:44am
tags:
GSK
Bayer’s Aleve May Have Lower Heart Risk Than Similar Pain Pills
Bloomberg
Tuesday, January 28, 2014 - 11:41am
tags:
Bayer, Aleve
For Meridian Bioscience, Living Up To The Past Could Prove Challenging
Seeking Alpha
Tuesday, January 28, 2014 - 11:39am
tags:
Meridian Bioscience, Illumigene
Analysis of FDA side-effect reports flags Sanofi, Celgene meds
Fierce Pharma
Tuesday, January 28, 2014 - 11:37am
tags:
Celegene, FDA, Sanofi, side effects, Pomalyst, Tecfidera, Biogen Idec, Aubagio
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Seeking Alpha
Tuesday, January 28, 2014 - 11:19am
tags:
Cellceutix, Brilacidin, Kevetrin, Cubist Pharmaceuticals, Epizyme, Geron
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tuesday, January 28, 2014 - 11:17am
tags:
Idenix, Pharma CEOs, Gilead Sciences, hepatitis C, Ron Renaud
Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Yahoo/AP
Tuesday, January 28, 2014 - 11:16am
tags:
Aratana, AT-005, animal health
Will Celgene (CELG) Miss This Earnings Season?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 11:15am
tags:
Celgene, earnings
Neuralstem: Sizing Up Potential Key Events Of 2014
Seeking Alpha
Tuesday, January 28, 2014 - 11:09am
tags:
Neuralstem, NSI-189, NSI-566, stem cells
Will Recent Headlines Hurt Pfizer Stock?
Wall St Cheat Sheet
Tuesday, January 28, 2014 - 10:56am
tags:
Pfizer
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan
Seeking Alpha
Tuesday, January 28, 2014 - 10:55am
tags:
OncoGenex, Isis Pharmaceuticals, Teva Pharmaceuticals, chemotherapy, OGX-011
3 Reasons to Focus on Diabetes
Motley Fool
Tuesday, January 28, 2014 - 10:53am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Xigduo, Pfizer
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Seeking Alpha
Tuesday, January 28, 2014 - 8:50am
tags:
Bristol-Myers Squibb, nivolumab, AstraZeneca
Johnson & Johnson Is Going Strong
Forbes
Tuesday, January 28, 2014 - 8:48am
tags:
JNJ
GE’s Immelt Urges More Private Investment in Africa Health Care
Bloomberg
Tuesday, January 28, 2014 - 8:46am
tags:
General Electric, Jeffrey Immelt, Africa
Drug critic slams FDA over antibiotic oversight in meat production
Yahoo/Reuters
Tuesday, January 28, 2014 - 8:44am
tags:
FDA, antibiotics, animal health
Why doctors should put down the iPad - study shows doctors using electronic records interact less with patients
Marketwatch
Tuesday, January 28, 2014 - 8:42am
tags:
iPad, physicians, electronic medical records
At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt
Bloomberg
Tuesday, January 28, 2014 - 8:37am
tags:
Gilead Sciences, hepatitis C, drug pricing, Sovaldi
Merck to Bristol-Myers Face More Threats on India Patents
Bloomberg
Tuesday, January 28, 2014 - 8:36am
tags:
Merck, India, patents, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.